▶ Grapefruit juice increases the exposure to propafenone.

Monitor and adjust dose.oStudy

▶ Dronedarone is predicted to increase the concentration of

guanfacine. Adjust guanfacine dose, p. 352.oTheoretical

▶ H2 receptor antagonists (cimetidine) increase the exposure to

amiodarone.oStudy

▶ H2 receptor antagonists (cimetidine) slightly increase the

exposure to flecainide. Monitor and adjust dose.nStudy

▶ H2 receptor antagonists (cimetidine) increase the exposure to

lidocaine. Monitor and adjust dose.oStudy

▶ H2 receptor antagonists (cimetidine) are predicted to increase

the exposure to

o

propafenone. Monitor and adjust dose.

Theoretical

▶ HIV-protease inhibitors are predicted to increase the exposure

to amiodarone. Avoid.rTheoretical → Also see TABLE 9

p. 1377

▶ HIV-protease inhibitors are predicted to increase the exposure

to disopyramide.rTheoretical → Also see TABLE 9 p. 1377

▶ HIV-protease inhibitors very markedly increase the exposure to

dronedarone. Avoid.rStudy → Also see TABLE 9 p. 1377

▶ HIV-protease inhibitors (ritonavir) are predicted to increase the

exposure to

Theoretical

flecainide. Avoid or monitor side effects.r

▶ HIV-protease inhibitors are predicted to increase the exposure

to lidocaine. Avoid.rStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to propafenone. Monitor and adjust dose.rStudy

▶ Amiodarone is predicted to increase the exposure to ibrutinib.

Adjust ibrutinib dose, p. 983.rTheoretical

▶ Dronedarone is predicted to increase the exposure to ibrutinib.

Adjust ibrutinib dose with moderate inhibitors of CYP3A4,

p. 983.rStudy

▶ Idelalisib is predicted to increase the exposure to amiodarone.

Avoid.oTheoretical

▶ Idelalisib very markedly increases the exposure to

dronedarone. Avoid.rStudy

▶ Idelalisib is predicted to increase the exposure to propafenone.

Monitor and adjust dose.rStudy

▶ Imatinib

r

is predicted to increase the exposure to dronedarone.

Theoretical

▶ Imatinib is predicted to increase the exposure to propafenone.

Monitor and adjust dose.oStudy

▶ Dronedarone is predicted to increase the exposure to

ivabradine. Adjust ivabradine dose, p. 211.rTheoretical

▶ Dronedarone is predicted to increase the exposure to ivacaftor.

Adjust ivacaftor p. 293 or tezacaftor with ivacaftor p. 295 dose

with moderate inhibitors of CYP3A4.rStudy

▶ Dronedarone

o

is predicted to increase the exposure to lapatinib.

Study → Also see TABLE 9 p. 1377

▶ Ledipasvir increases the risk of severe bradycardia or heart

block when given with amiodarone. Refer to specialist

literature.rAnecdotal

▶ Letermovir is predicted to increase the concentration of

amiodarone.oTheoretical

▶ Amiodarone is predicted to increase the exposure to

lomitapide

Theoretical

. Separate administration by 12 hours.o ▶ Dronedarone is predicted to increase the exposure to

lomitapide. Avoid.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

loperamide.rTheoretical

▶ Dronedarone is predicted to increase the exposure to

lurasidone. Adjust lurasidone dose, p. 398.oStudy

▶ Macrolides (clarithromycin) very markedly increase the

exposure to dronedarone. Avoid.rStudy → Also see TABLE 9

p. 1377

▶ Macrolides (clarithromycin) are predicted to increase the

exposure to

Study

propafenone. Monitor and adjust dose.r

▶ Macrolides (clarithromycin, erythromycin) are predicted to

increase the exposure to lidocaine.oTheoretical

▶ Macrolides (erythromycin) are predicted to moderately increase

the exposure to dronedarone. Avoid.rTheoretical → Also

see TABLE 9 p. 1377

▶ Macrolides (erythromycin) are predicted to increase the

exposure to

Study

propafenone. Monitor and adjust dose.o ▶ Mexiletine increases the risk of torsade de pointes when given

with antiarrhythmics. Avoid.rTheoretical

▶ Dronedarone is predicted to increase the exposure to

midazolam. Monitor side effects and adjust dose.rStudy

▶ Dronedarone is predicted to increase the exposure to

midostaurin.oTheoretical

▶ Mitotane is predicted to decrease the exposure to

antiarrhythmics

Study

(disopyramide, dronedarone). Avoid.r

▶ Mitotane

o

is predicted to decrease the efficacy of propafenone.

Study

▶ Dronedarone increases the risk of neutropenia when given

with monoclonal antibodies (brentuximab vedotin). Monitor and

adjust dose.rTheoretical

▶ Dronedarone is predicted to increase the exposure to

naloxegol

o

. Adjust naloxegol dose and monitor side effects, p. 65.

Study

▶ Netupitant is predicted to increase the exposure to

propafenone. Monitor and adjust dose.oStudy

▶ Nevirapine is predicted to decrease the exposure to

dronedarone.rTheoretical

▶ Nilotinib is predicted to increase the exposure to propafenone.

Monitor and adjust dose.oStudy

▶ Antiarrhythmics (amiodarone, dronedarone) are predicted to

increase the exposure to nintedanib.oStudy

▶ NSAIDs (celecoxib) are predicted to increase the exposure to

antiarrhythmics (flecainide, propafenone). Monitor and adjust

dose.oTheoretical

▶ Dronedarone is predicted to increase the exposure to olaparib.

Avoid moderate inhibitors of CYP3A4 or adjust olaparib dose,

p. 1005.oTheoretical

▶ Dronedarone is predicted to increase the exposure to opioids

(alfentanil, buprenorphine, fentanyl, oxycodone). Monitor and

adjust dose.oStudy

▶ Amiodarone is predicted to increase the concentration of

opioids (fentanyl).oTheoretical → Also see TABLE 6 p. 1376

▶ Dronedarone is predicted to increase the exposure to opioids

(methadone, sufentanil).oTheoretical → Also see TABLE 9

p. 1377

▶ Dronedarone is predicted to increase the exposure to

oxybutynin.nTheoretical

▶ Antiarrhythmics (amiodarone, dronedarone) are predicted to

increase the exposure to

Theoretical → Also see TABLE 9

panobinostat

p. 1377

. Adjust dose.o ▶ Dronedarone is predicted to increase the exposure to

pazopanib.oTheoretical → Also see TABLE 9 p. 1377

▶ Propafenone is predicted to increase the anticoagulant effect

of phenindione. Monitor and adjust dose.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

phosphodiesterase type-5 inhibitors (avanafil). Adjust avanafil

dose, p. 812.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

phosphodiesterase type-5 inhibitors (sildenafil). Monitor or

adjust sildenafil dose with moderate inhibitors of CYP3A4,

p. 813.oStudy → Also see TABLE 9 p. 1377

▶ Dronedarone is predicted to increase the exposure to

phosphodiesterase type-5 inhibitors (tadalafil).rTheoretical

▶ Dronedarone is predicted to increase the exposure to

phosphodiesterase type-5 inhibitors

r

(vardenafil). Adjust dose.

Theoretical → Also see TABLE 9 p. 1377

▶ Amiodarone is predicted to increase the exposure to

pibrentasvir.oTheoretical

▶ Dronedarone potentially increases the exposure to

pibrentasvir.oTheoretical

▶ Dronedarone is predicted to increase the exposure to pimozide.

Avoid.rTheoretical → Also see TABLE 9 p. 1377

▶ Dronedarone is predicted to increase the exposure to

quetiapine. Avoid.oStudy

▶ Quinolones (ciprofloxacin) slightly increase the exposure to

lidocaine.nStudy

▶ Dronedarone is predicted to increase the exposure to

ranolazine.rStudy → Also see TABLE 9 p. 1377

BNF 78 Antiarrhythmics — Antiarrhythmics 1389

Interactions | Appendix 1

A1

Antiarrhythmics (continued)

▶ Amiodarone is predicted to increase the exposure to retinoids

(alitretinoin)

Theoretical

. Adjust alitretinoin dose, p. 1262.o ▶ Ribociclib (high-dose) is predicted to increase the exposure to

amiodarone. Avoid.oTheoretical → Also see TABLE 9

p. 1377

▶ Dronedarone is predicted to increase the exposure to

ribociclib.oStudy → Also see TABLE 9 p. 1377

▶ Rifampicin is predicted to decrease the exposure to

antiarrhythmics

Study

(disopyramide, dronedarone). Avoid.r

▶ Rifampicin

o

is predicted to decrease the efficacy of propafenone.

Study

▶ Dronedarone is predicted to increase the exposure to

rivaroxaban. Avoid.oTheoretical

▶ Rolapitant is predicted to increase the exposure to

propafenone.rStudy

▶ Dronedarone is predicted to increase the exposure to

ruxolitinib.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

saxagliptin.nStudy

▶ Amiodarone is predicted to increase the concentration of

sirolimus.rAnecdotal

▶ Dronedarone increases the concentration of sirolimus. Monitor

and adjust dose.oStudy

▶ Sofosbuvir is predicted to increase the risk of severe

bradycardia or heart block when given with amiodarone. Refer

to specialist literature.rAnecdotal

▶ SSRIs (fluvoxamine) are predicted to increase the exposure to

propafenone. Monitor and adjust dose.oStudy

▶ Dronedarone is predicted to increase the exposure to SSRIs

(citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine,

sertraline).rTheoretical → Also see TABLE 9 p. 1377

▶ Dronedarone is predicted to increase the exposure to SSRIs

(dapoxetine). Adjust dapoxetine dose with moderate inhibitors

of CYP3A4, p. 821.oTheoretical

▶ St John’s Wort is predicted to decrease the exposure to

dronedarone. Avoid.rTheoretical

▶ Amiodarone is predicted to increase the risk of rhabdomyolysis

when given with statins (atorvastatin). Monitor and adjust

dose.oTheoretical

▶ Dronedarone is predicted to increase the exposure to statins

(atorvastatin). Monitor and adjust dose.rStudy

▶ Amiodarone is predicted to increase the exposure to statins

(fluvastatin).rTheoretical

▶ Dronedarone slightly increases the exposure to statins

(rosuvastatin). Adjust dose.rStudy

▶ Amiodarone increases the risk of rhabdomyolysis when given

with

r

statins (simvastatin). Adjust simvastatin dose, p. 205.

Study

▶ Dronedarone is predicted to increase the exposure to statins

(simvastatin). Use with caution and adjust simvastatin dose,

p. 205.rStudy

▶ Amiodarone is predicted to increase the exposure to

sulfonylureas

Study

. Use with caution and adjust dose.o ▶ Dronedarone

o

is predicted to increase the exposure to sunitinib.

Theoretical → Also see TABLE 9 p. 1377

▶ Lidocaine is predicted to increase the effects of

suxamethonium.oStudy

▶ Amiodarone is predicted to increase the concentration of

tacrolimus.rAnecdotal

▶ Dronedarone is predicted to increase the concentration of

tacrolimus.rStudy

▶ Dronedarone is predicted to increase the exposure to taxanes

(cabazitaxel).oTheoretical

▶ Dronedarone is predicted to increase the exposure to taxanes

(paclitaxel).rTheoretical

▶ Dronedarone is predicted to increase the concentration of

temsirolimus.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

tezacaftor. Adjust tezacaftor with ivacaftor p. 295 dose with

moderate inhibitors of CYP3A4.rStudy

▶ Theophylline decreases the efficacy of adenosine. Separate

administration by 24 hours.nStudy

▶ Amiodarone is predicted to increase the risk of thyroid

dysfunction when given with

o

thyroid hormones. Avoid.

Study

▶ Amiodarone is predicted to increase the exposure to ticagrelor.

Use with caution or avoid.rStudy

▶ Dronedarone given with a potent CYP2C19 inhibitor is

predicted to increase the exposure to tofacitinib. Adjust

tofacitinib dose, p. 1105.oStudy

▶ Dronedarone is predicted to increase the exposure to

tolterodine.nTheoretical → Also see TABLE 9 p. 1377

▶ Dronedarone is predicted to increase the exposure to

tolvaptan. Manufacturer advises caution or adjust tolvaptan

dose with moderate inhibitors of CYP3A4,

Study

p. 669.o ▶ Antiarrhythmics (amiodarone, dronedarone) are predicted to

increase the exposure to topotecan.rStudy

▶ Antiarrhythmics (amiodarone, dronedarone) are predicted to

increase the concentration of trametinib.oTheoretical

▶ Dronedarone is predicted to increase the exposure to

trazodone.oTheoretical

▶ Dronedarone is predicted to increase the exposure to tricyclic

antidepressants. Avoid.rTheoretical → Also see TABLE 9

p. 1377

▶ Propafenone is predicted to increase the concentration of

tricyclic antidepressants.oTheoretical → Also see TABLE 10

p. 1377

▶ Dronedarone is predicted to increase the exposure to ulipristal.

Avoid if used for uterine fibroids.oStudy

▶ Amiodarone is predicted to increase the concentration of

velpatasvir. Avoid or monitor.oTheoretical

▶ Amiodarone is predicted to increase the exposure to

venetoclax. Avoid or monitor for toxicity.rTheoretical

▶ Dronedarone is predicted to increase the exposure to

venetoclax

r

. Avoid or adjust dose—consult product literature.

Study

▶ Dronedarone is predicted to increase the exposure to vinca

alkaloids.rTheoretical → Also see TABLE 9 p. 1377

▶ Dronedarone is predicted to increase the exposure to

zopiclone. Adjust dose.oStudy

Anticholinesterases, centrally acting → see TABLE 6 p. 1376

(bradycardia)

donepezil . galantamine .rivastigmine. ▶ Antiarrhythmics (amiodarone) increase the risk of bradycardia

when given with

Anecdotal → Also see

anticholinesterases, centrally acting

TABLE 6 p. 1376

.o ▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to donepezil.nStudy

▶ Antifungals, azoles (itraconazole, ketoconazole, voriconazole) are

predicted to increase the exposure to galantamine. Monitor

and adjust dose.oStudy

▶ Anticholinesterases, centrally acting are predicted to increase

the risk of bradycardia when given with beta blockers, nonselective.oAnecdotal → Also see TABLE 6 p. 1376

▶ Anticholinesterases, centrally acting are predicted to increase

the risk of bradycardia when given with beta blockers,

selective.oAnecdotal → Also see TABLE 6 p. 1376

▶ Bupropion is predicted to increase the exposure to

galantamine. Monitor and adjust dose.oStudy

▶ Calcium channel blockers (diltiazem, verapamil) increase the risk

of bradycardia when given with anticholinesterases, centrally

acting.oAnecdotal → Also see TABLE 6 p. 1376

▶ Cinacalcet is predicted to increase the exposure to

galantamine. Monitor and adjust dose.oStudy

▶ Cobicistat is predicted to increase the exposure to

galantamine. Monitor and adjust dose.oStudy

▶ Enzalutamide is predicted to decrease the exposure to

donepezil.nStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to galantamine. Monitor and adjust dose.oStudy

▶ Idelalisib is predicted to increase the exposure to galantamine.

Monitor and adjust dose.oStudy

1390 Antiarrhythmics — Anticholinesterases, centrally acting BNF 78

Interactions | Appendix 1

A1

▶ Macrolides (clarithromycin) are predicted to increase the

exposure to

Study

galantamine. Monitor and adjust dose.o ▶ Mitotane is predicted to decrease the exposure to donepezil.

nStudy

▶ Anticholinesterases, centrally acting are predicted to decrease

the effects of

o

neuromuscular blocking drugs, non-depolarising.

Theoretical → Also see TABLE 6 p. 1376

▶ Rifampicin is predicted to decrease the exposure to donepezil.

nStudy

▶ SSRIs (fluoxetine, paroxetine) are predicted to increase the

exposure to

Study

galantamine. Monitor and adjust dose.o ▶ Anticholinesterases, centrally acting increase the effects of

suxamethonium.oTheoretical

▶ Terbinafine is predicted to increase the exposure to

galantamine. Monitor and adjust dose.oStudy

Antiepileptics → see TABLE 1 p. 1375 (hepatotoxicity), TABLE 18 p. 1379

(hyponatraemia), TABLE 15 p. 1378 (myelosuppression), TABLE 12 p. 1378

(peripheral neuropathy), TABLE 11 p. 1377 (CNS depressant effects)

brivaracetam . carbamazepine . eslicarbazepine . ethosuximide . fosphenytoin . gabapentin . lacosamide . lamotrigine . levetiracetam. oxcarbazepine . paraldehyde . perampanel . phenobarbital . phenytoin . pregabalin . primidone .retigabine . rufinamide . stiripentol .tiagabine .topiramate .valproate . vigabatrin . zonisamide.

FOOD AND LIFESTYLE Avoid taking milk, dairy products,

carbonated drinks, fruit juices, or caffeine-containing food

and drinks at the same time as stiripentol.

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to abacavir.oTheoretical

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to markedly decrease the

exposure to abemaciclib. Avoid.rStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to abiraterone. Avoid.rStudy

▶ Acetazolamide potentially increases the risk of toxicity when

given with valproate.rStudy

▶ Acetazolamide potentially increases the risk of overheating

and dehydration when given with zonisamide. Avoid in

children.rTheoretical

▶ Carbamazepine is predicted to decrease the exposure to

afatinib.oStudy

▶ Antiepileptics (fosphenytoin, phenytoin) are predicted to

decrease the exposure to agomelatine.oTheoretical

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) decrease the concentration of

albendazole.oStudy

▶ Alcohol (beverage) potentially increases the risk of visual

disturbances when given with retigabine.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to

Theoretical

aldosterone antagonists

→ Also see TABLE 18

(eplerenone)

p. 1379

. Avoid.o ▶ Carbamazepine

Study

decreases the exposure to aliskiren.o ▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to alprazolam. Adjust dose.oTheoretical → Also see

TABLE 11 p. 1377

▶ Fosphenytoin is predicted to decrease the exposure to

aminophylline. Adjust dose.oStudy

▶ Phenobarbital is predicted to decrease the exposure to

aminophylline. Adjust dose.oTheoretical

▶ Phenytoin decreases the exposure to aminophylline. Adjust

dose.oStudy

▶ Primidone is predicted to increase the clearance of

aminophylline. Adjust dose.oTheoretical

▶ Stiripentol is predicted to increase the exposure to

aminophylline. Avoid.oTheoretical

▶ Antiepileptics (fosphenytoin, phenobarbital, phenytoin,

primidone) are predicted to increase the risk of

methaemoglobinaemia when given with topical anaesthetics,

Theoretical

local (prilocaine)

→ Also see

. Use with caution or avoid.

TABLE 11 p. 1377

r

▶ Phenytoin is predicted to decrease the exposure to

anaesthetics, local (ropivacaine).oTheoretical

▶ Antacids decrease the absorption of gabapentin. Gabapentin

should be taken 2 hours after antacids.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to

Study

antiarrhythmics (disopyramide, dronedarone). Avoid.r

▶ Antiarrhythmics (amiodarone) are predicted to slightly increase

the concentration of antiepileptics (fosphenytoin, phenytoin).

Monitor and adjust dose.rStudy → Also see TABLE 12 p. 1378

▶ Antiepileptics (fosphenytoin, phenytoin) are predicted to

decrease the exposure to

Anecdotal

antiarrhythmics (lidocaine).r

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the efficacy of

antiarrhythmics (propafenone).oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to anticholinesterases, centrally acting (donepezil).nStudy

▶ Antiepileptics (carbamazepine) decrease the concentration of

antiepileptics (brivaracetam).oStudy

▶ Antiepileptics (fosphenytoin, phenytoin) decrease the

concentration of antiepileptics (brivaracetam).oStudy

▶ Antiepileptics (lamotrigine) potentially increase the

concentration of antiepileptics (carbamazepine) and

antiepileptics (carbamazepine) decrease the concentration of

antiepileptics (lamotrigine). Adjust lamotrigine dose and

monitor

Study

carbamazepine concentration, p. 318, p. 311.o ▶ Antiepileptics (phenobarbital) affect the concentration of

antiepileptics (carbamazepine) and antiepileptics

(carbamazepine) increase the concentration of antiepileptics

(phenobarbital). Adjust dose.oStudy

▶ Antiepileptics (topiramate) increase the risk of carbamazepine

toxicity when given with

o

antiepileptics (carbamazepine).

Study

▶ Antiepileptics (stiripentol) increase the concentration of

antiepileptics (carbamazepine, phenobarbital). Avoid in Dravet

syndrome.rStudy

▶ Antiepileptics (carbamazepine) slightly decrease the exposure

to antiepileptics (eslicarbazepine, oxcarbazepine). Monitor and

adjust dose.oStudy

▶ Antiepileptics (oxcarbazepine) are predicted to increase the

concentration of antiepileptics (fosphenytoin). Monitor

concentration and adjust dose.oStudy

▶ Antiepileptics (stiripentol) are predicted to increase the

concentration of antiepileptics (fosphenytoin).rStudy

▶ Antiepileptics (carbamazepine) affect the concentration of

antiepileptics (fosphenytoin, phenytoin) and antiepileptics

(fosphenytoin, phenytoin) decrease the concentration of

antiepileptics

Study

(carbamazepine). Monitor and adjust dose.r

▶ Antiepileptics (eslicarbazepine) increase the exposure to

antiepileptics (fosphenytoin, phenytoin) and antiepileptics

(fosphenytoin, phenytoin) decrease the exposure to

antiepileptics

o

(eslicarbazepine). Monitor and adjust dose.

Study

▶ Antiepileptics (valproate) affect the concentration of

antiepileptics (fosphenytoin, phenytoin) and antiepileptics

(fosphenytoin, phenytoin) decrease the concentration of

antiepileptics (valproate).rStudy

▶ Antiepileptics (vigabatrin) decrease the concentration of

antiepileptics (fosphenytoin, phenytoin).nStudy

▶ Antiepileptics (fosphenytoin) decrease the concentration of

antiepileptics (lamotrigine). Monitor and adjust lamotrigine

dose, p. 318.oStudy

▶ Antiepileptics (phenobarbital, phenytoin, primidone) decrease

the concentration of antiepileptics (lamotrigine). Monitor and

adjust lamotrigine dose, p. 318.oStudy → Also see

TABLE 11 p. 1377

BNF 78 Anticholinesterases, centrally acting — Antiepileptics 1391

Interactions | Appendix 1

A1

Antiepileptics (continued)

▶ Antiepileptics (valproate) increase the exposure to antiepileptics

(lamotrigine)

r

. Adjust lamotrigine dose and monitor rash, p. 318.

Study

▶ Antiepileptics (lamotrigine) are predicted to increase the

concentration of antiepileptics (oxcarbazepine) and

antiepileptics (oxcarbazepine) are predicted to decrease the

concentration of antiepileptics (lamotrigine). Monitor side

effects and adjust dose.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin) are predicted to

decrease the exposure to antiepileptics (perampanel). Monitor

and adjust dose.oStudy

▶ Antiepileptics (oxcarbazepine) decrease the concentration of

antiepileptics (perampanel) and antiepileptics (perampanel)

increase the concentration of antiepileptics (oxcarbazepine).

Monitor and adjust dose.oStudy

▶ Antiepileptics (phenobarbital, phenytoin, primidone) are

predicted to decrease the exposure to antiepileptics

(perampanel). Monitor and adjust dose.oStudy → Also

see TABLE 11 p. 1377

▶ Antiepileptics (phenytoin) increase the concentration of

antiepileptics (phenobarbital) and antiepileptics (phenobarbital)

affect the concentration of

Study

antiepileptics (phenytoin).o ▶ Antiepileptics (fosphenytoin) increase the concentration of

antiepileptics (phenobarbital, primidone) and antiepileptics

(phenobarbital, primidone) affect the concentration of

antiepileptics (fosphenytoin).oStudy

▶ Antiepileptics (oxcarbazepine) are predicted to increase the

concentration of antiepileptics (phenytoin). Monitor

concentration and adjust dose.oStudy

▶ Antiepileptics (stiripentol) are predicted to increase the

concentration of antiepileptics (phenytoin). Avoid in Dravet

syndrome.rStudy

▶ Antiepileptics (carbamazepine) potentially decrease the

concentration of antiepileptics (primidone) and antiepileptics

(primidone) potentially decrease the concentration of

antiepileptics (carbamazepine). Adjust dose.oAnecdotal

▶ Antiepileptics (phenytoin) increase the concentration of

antiepileptics (primidone) and antiepileptics (primidone) affect

the concentration of antiepileptics (phenytoin).oStudy

▶ Antiepileptics (stiripentol) are predicted to increase the

concentration of antiepileptics (primidone).rTheoretical

▶ Antiepileptics (valproate) affect the concentration of

antiepileptics

Study

(primidone). Monitor and adjust dose.r

▶ Antiepileptics (carbamazepine) slightly increase the clearance

of antiepileptics (retigabine).oStudy

▶ Antiepileptics (fosphenytoin, phenytoin) are predicted to slightly

increase the clearance of

Study

antiepileptics (retigabine).o ▶ Antiepileptics (valproate) increase the exposure to antiepileptics

(rufinamide). Adjust rufinamide dose, p. 326.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) decrease the exposure to antiepileptics

(tiagabine)

Study

. Monitor and adjust tiagabine dose, p. 331.o ▶ Antiepileptics (fosphenytoin, phenytoin) decrease the

concentration of antiepileptics (topiramate) and antiepileptics

(topiramate) increase the concentration of antiepileptics

(fosphenytoin, phenytoin)

Study

. Monitor and adjust dose.o ▶ Antiepileptics (phenobarbital, primidone) are predicted to

decrease the concentration of antiepileptics (topiramate).n

Study

▶ Antiepileptics (phenobarbital) decrease the concentration of

antiepileptics (valproate) and antiepileptics (valproate) increase

the concentration of antiepileptics (phenobarbital). Monitor

and adjust dose.oStudy

▶ Antiepileptics (topiramate) increase the risk of toxicity when

given with antiepileptics (valproate).rStudy

▶ Antiepileptics (carbamazepine) slightly to moderately decrease

the concentration of antiepileptics (zonisamide) and

antiepileptics (zonisamide) affect the concentration of

o

antiepileptics (carbamazepine). Monitor and adjust dose.

Study

▶ Antiepileptics (fosphenytoin, phenytoin) slightly to moderately

decrease the concentration of antiepileptics (zonisamide).

Monitor and adjust dose.oStudy

▶ Antiepileptics (phenobarbital, primidone) are predicted to

decrease the concentration of antiepileptics (zonisamide).

Monitor and adjust dose.oStudy

▶ Antiepileptics (topiramate) potentially increase the risk of

overheating and dehydration when given with antiepileptics

(zonisamide). Avoid in children.rTheoretical

▶ Antifungals, azoles (itraconazole, ketoconazole, voriconazole) are

predicted to very slightly increase the exposure to

perampanel.nStudy

▶ Antifungals, azoles (miconazole) increase the risk of

carbamazepine toxicity when given with carbamazepine.

Monitor and adjust dose.rAnecdotal

▶ Antifungals, azoles (miconazole) increase the risk of phenytoin

toxicity when given with fosphenytoin. Monitor and adjust

dose.rAnecdotal

▶ Antifungals, azoles (miconazole) increase the risk of phenytoin

toxicity when given with

r

phenytoin. Monitor and adjust dose.

Anecdotal

▶ Carbamazepine is predicted to decrease the efficacy of

antifungals, azoles (fluconazole) and antifungals, azoles

(fluconazole) increase the concentration of carbamazepine.

Avoid or monitor carbamazepine concentration and adjust

dose accordingly, p. 311.rTheoretical → Also see TABLE 1

p. 1375

▶ Antifungals, azoles (fluconazole) increase the concentration of

antiepileptics (fosphenytoin, phenytoin). Monitor concentration

and adjust dose.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to antifungals, azoles (isavuconazole). Avoid.rStudy

▶ Fosphenytoin very markedly decreases the exposure to

antifungals, azoles (itraconazole). Avoid and for 14 days after

stopping fosphenytoin.oStudy

▶ Phenobarbital decreases the concentration of antifungals,

azoles (itraconazole). Avoid and for 14 days after stopping

phenobarbital.oStudy

▶ Phenytoin very markedly decreases the exposure to antifungals,

azoles (itraconazole). Avoid and for 14 days after stopping

phenytoin.oStudy

▶ Primidone is predicted to decrease the concentration of

antifungals, azoles (itraconazole).oTheoretical

▶ Carbamazepine is predicted to decrease the efficacy of

antifungals, azoles (itraconazole, voriconazole) and antifungals,

azoles (itraconazole, voriconazole) increase the concentration

of carbamazepine. Avoid or adjust dose.oTheoretical →

Also see TABLE 1 p. 1375

▶ Carbamazepine is predicted to decrease the efficacy of

antifungals, azoles (ketoconazole) and antifungals, azoles

(ketoconazole) slightly increase the concentration of

carbamazepine. Avoid or monitor carbamazepine

concentration and adjust dose accordingly,

Study

p. 311.o ▶ Phenobarbital is predicted to decrease the concentration of

antifungals, azoles (ketoconazole). Avoid.oStudy

▶ Antiepileptics (fosphenytoin, phenytoin) decrease the exposure

to antifungals, azoles (ketoconazole). Avoid.oStudy

▶ Primidone is predicted to decrease the concentration of

o

antifungals, azoles (ketoconazole, posaconazole). Avoid.

Study

▶ Carbamazepine is predicted to decrease the efficacy of

antifungals, azoles (posaconazole) and antifungals, azoles

(posaconazole) increase the concentration of carbamazepine.

Avoid.oTheoretical

▶ Phenobarbital is predicted to decrease the concentration of

antifungals, azoles (posaconazole). Avoid.oStudy

▶ Antiepileptics (fosphenytoin, phenytoin) are predicted to

decrease the exposure to antifungals, azoles (posaconazole).

Avoid.oStudy

▶ Fosphenytoin decreases the exposure to antifungals, azoles

(voriconazole) and antifungals, azoles (voriconazole) increase

1392 Antiepileptics — Antiepileptics BNF 78

Interactions | Appendix 1

A1

the exposure to fosphenytoin. Avoid or adjust voriconazole

dose and monitor phenytoin concentration,

Study

p. 599.o ▶ Phenytoin decreases the exposure to antifungals, azoles

(voriconazole) and antifungals, azoles (voriconazole) increase

the exposure to phenytoin. Avoid or adjust voriconazole dose

and monitor

Study

phenytoin concentration, p. 599, p. 323.o ▶ Antiepileptics (phenobarbital, primidone) are predicted to

decrease the concentration of antifungals, azoles (voriconazole).

Avoid.oTheoretical

▶ Antihistamines, sedating (hydroxyzine) potentially increase the

risk of overheating and dehydration when given with

zonisamide. Avoid in children.rTheoretical

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to

r

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more